Investors

Shareholders Information

The Company's ordinary shares are listed and trade on the London Stock Exchange AIM market.

Shares in issue 
33,250,000,000 Ordinary Shares of 0.000001p each.
There are no restrictions on the transfer of the company's securities.

Significant & Directors' Shareholdings

https://www.ambienpharmacy.org

Designation Shareholder Name Amount % Holding
XPIDEAL PUMA NOMINEES LIMITED 3,505,947,461 10%
15942 HARGREAVES LANSDOWN (NOMINEES) LIMITED 2,693,460,894 7%
SMKTISAS INTERACTIVE INVESTOR SERVICES NOMINEES LIMITED 2,218,338,197 6%
UKOGCCN MUFG CORPORATE MARKETS TRUSTEES (NOMINEES) LIMITED 1,824,912,685 5%
VRA HARGREAVES LANSDOWN (NOMINEES) LIMITED 1,639,672,539 4%
IGUKCLT VIDACOS NOMINEES LIMITED 1,613,038,127 4%
  THE BANK OF NEW YORK (NOMINEES) LIMITED 1,373,926,825 4%
HLNOM   HARGREAVES LANSDOWN (NOMINEES) LIMITED 1,323,826,147 4%
CLIENT1   BARCLAYS DIRECT INVESTING NOMINEES LIMITED 1,306,734,186 4%
CFE CANTOR FITZGERALD EUROPE 1,198,173,491 3%
  HSDL NOMINEES LIMITED 956,300,160 3%
       
       
       
       


The total percentage of shares not in public hands is 0.07% defined as being beneficial holdings of shares held by shareholders holding above 10% and the directors holdings.


Last updated: 22 January 2026